|
Post by slugworth008 on Nov 21, 2016 12:10:45 GMT -5
Don't see much in the way of PPS appreciation until 2017 IMO - unless of course some material event is unexpectedly announced. But that's not likely IMO.
I'd like to wish all MNKD longs and esteemed Proboard members a very Happy Thanksgiving !!!
I'm going to attempt to NOT watch the PPS until Jan 2 (LOL - right - LOL) Okay so where is that "squeeze email notification setting?
|
|
|
Post by silentknight on Nov 21, 2016 12:40:18 GMT -5
Matt said in the last CC that he expected the delisting issue to take care of itself in light of the cleaned up balance sheet. I think he's very very much mistaken.
You saw an initial pop, and every day since has been a slow and steady sell off of anywhere between one to three cents. We now sit at .61 per share, lower than we were when SNY pulled the plug in Jan.
The only way the share price goes up is 1) sell Afrezza, 2) announce a positive material event, or 3) reverse split.
I don't see either of the first two happening before the delisting window closes, so I still think we see a R/S within the next few months. For a biotech with an approved product on the market, the street cares about revenue and MNKD has next to none of it.
|
|
|
Post by babaoriley on Nov 21, 2016 13:25:17 GMT -5
"I think he's very very much mistaken." You know, Matt can't be wrong all the time.
|
|
|
Post by cjc04 on Nov 21, 2016 13:39:52 GMT -5
Matt said in the last CC that he expected the delisting issue to take care of itself in light of the cleaned up balance sheet. I think he's very very much mistaken. You saw an initial pop, and every day since has been a slow and steady sell off of anywhere between one to three cents. We now sit at .61 per share, lower than we were when SNY pulled the plug in Jan. The only way the share price goes up is 1) sell Afrezza, 2) announce a positive material event, or 3) reverse split. I don't see either of the first two happening before the delisting window closes, so I still think we see a R/S within the next few months. For a biotech with an approved product on the market, the street cares about revenue and MNKD has next to none of it. That is not what Matt said........ I do not recall the exact quote, but it was something like,,,, we expect the delisting issue to take care of itself based on events in the beginning of the year.
|
|
|
Post by careful2invest on Nov 21, 2016 13:42:47 GMT -5
"I think he's very very much mistaken." You know, Matt can't be wrong all the time. My bet is that Matt knows something that he has yet to share with us to prevent a Nasdaq delisting issue. Lets hope at least, right? He and Mike have overcome many major obstacles thus far, clearly with more on the horizon, but we've come too far to not make AFREZZA a success at the finish line. GLTA TRUE LONGS
|
|
|
Post by sla55 on Nov 21, 2016 14:01:22 GMT -5
Matt said in the last CC that he expected the delisting issue to take care of itself in light of the cleaned up balance sheet. I think he's very very much mistaken. You saw an initial pop, and every day since has been a slow and steady sell off of anywhere between one to three cents. We now sit at .61 per share, lower than we were when SNY pulled the plug in Jan. The only way the share price goes up is 1) sell Afrezza, 2) announce a positive material event, or 3) reverse split. I don't see either of the first two happening before the delisting window closes, so I still think we see a R/S within the next few months. For a biotech with an approved product on the market, the street cares about revenue and MNKD has next to none of it. That is not what Matt said........ I do not recall the exact quote, but it was something like,,,, we expect the delisting issue to take care of itself based on events in the beginning of the year. From the edited transcript of MNKD earnings conference call or presentation: " One of the most frequently asked questions that are coming through in the online way to ask has to do with delisting. I'm not sure what exactly to say about that. I am not terribly concerned about delisting. I think the news today will go a long way to solving that problem. It's not going to be an issue until sometime in the second quarter of next year, by which point we expect to have a lot of things accomplished that will make this whole issue go away."
|
|
Deleted
Deleted Member
Posts: 0
|
Ho-Hum
Nov 21, 2016 14:15:56 GMT -5
Post by Deleted on Nov 21, 2016 14:15:56 GMT -5
Matt stated the improved cash would help towards moving the needle. On top of accomplishments by MNKD thatwould resolve the issue by time something needs to be done. He didnt not state specific time or event. R/S is not in the cards but they wont rule it out either if its the only option they have left.
|
|
|
Ho-Hum
Nov 21, 2016 14:16:27 GMT -5
Post by slugworth008 on Nov 21, 2016 14:16:27 GMT -5
That is not what Matt said........ I do not recall the exact quote, but it was something like,,,, we expect the delisting issue to take care of itself based on events in the beginning of the year. From the edited transcript of MNKD earnings conference call or presentation: " One of the most frequently asked questions that are coming through in the online way to ask has to do with delisting. I'm not sure what exactly to say about that. I am not terribly concerned about delisting. I think the news today will go a long way to solving that problem. It's not going to be an issue until sometime in the second quarter of next year, by which point we expect to have a lot of things accomplished that will make this whole issue go away." Thank you for clarifying!!!!
|
|
|
Post by kc on Nov 21, 2016 14:55:18 GMT -5
"I think he's very very much mistaken." You know, Matt can't be wrong all the time. I would like to believe that one Monday Morning we will wake up to some kind of news. Perhaps before the end of the time frame for delisting. I guess that my glass is almost 98% empty.
|
|
|
Ho-Hum
Nov 21, 2016 20:48:17 GMT -5
Post by falconquest on Nov 21, 2016 20:48:17 GMT -5
"I am not terribly concerned about delisting. I think the news today will go a long way to solving that problem".
Well let's see, prior to the conference call the share price was in a steady rate of decline. Just prior to the call we had a bit of a jump up. Since then we have resumed our steady rate downward. I guess that wasn't such a good call on Matt's part. The street wants to see revenue. Matt put a tourniquet on the bleeding wound but we have not yet healed. Sales is the healer and the only healer. Get the product accepted in the market place and the share price will take care of itself. Once the market sees product acceptance we will be much better off. IMHO
|
|
|
Post by nylefty on Nov 21, 2016 21:08:53 GMT -5
Well let's see, prior to the conference call the share price was in a steady rate of decline. Just prior to the call we had a bit of a jump up. Since then we have resumed our steady rate downward. I guess that wasn't such a good call on Matt's part. Wrong. MNKD closed at .4656 at 4 PM on November 9th, an hour before the call. Since then it's UP 30.9 percent.
|
|
|
Post by sportsrancho on Nov 21, 2016 22:23:23 GMT -5
Just in general. Want to thank you nylefty for your clarification on so many things. From pps to billboards:-)
|
|
|
Post by nylefty on Nov 21, 2016 23:03:21 GMT -5
Just in general. Want to thank you nylefty for your clarification on so many things. From pps to billboards:-) Thanks, Sports. Glad you don't agree with the poster who accused me of being a "troll" -- and thanks to you for all your valuable contributions.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 22, 2016 0:03:44 GMT -5
The stock is on the move downward over the past 4-5 trading days there's no arguing that. So you could either be up if you bought prior to the call or about flat if you bought in AH after the call. Either way the moves in MNKD are to volatile to buy and hold. You have 20% profits you take them and live to fight another day. Buying and holding at this point is the definition of insanity with a touch of sadism.
|
|
|
Post by nylefty on Nov 22, 2016 0:33:34 GMT -5
The stock is on the move downward over the past 4-5 trading days there's no arguing that. So you could either be up if you bought prior to the call or about flat if you bought in AH after the call. Either way the moves in MNKD are to volatile to buy and hold. You have 20% profits you take them and live to fight another day. Buying and holding at this point is the definition of insanity with a touch of sadism. It's down less than two cents a share in the past four trading days, four cents in the past five trading days, and less than one cent since the close on the day after the last conference call. "On the move downward?"...right. Call me a sadistic madman, but I think this is a good entry point.
|
|